Prognostic Value of Inflammatory and Nutritional Biomarkers of Immune Checkpoint Inhibitor Treatment for Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

SIMPLE SUMMARY: In recent years, various biomarkers have been developed to assist in the selection of anticancer agents. Inflammatory and nutritional biomarkers have been reported as useful for predicting prognosis after treatment with immune checkpoint inhibitor (ICI) treatment in head and neck can...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakai, Akihiro, Iijima, Hiroaki, Ebisumoto, Koji, Yamauchi, Mayu, Teramura, Takanobu, Yamazaki, Aritomo, Watanabe, Takane, Inagi, Toshihide, Maki, Daisuke, Okami, Kenji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093403/
https://www.ncbi.nlm.nih.gov/pubmed/37046684
http://dx.doi.org/10.3390/cancers15072021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093403/
https://www.ncbi.nlm.nih.gov/pubmed/37046684
http://dx.doi.org/10.3390/cancers15072021

Ejemplares similares